When Your Genome Costs Less Than Your iPhone: The Beautiful, Terrifying Future of DNA Sequencing
By Jo Best,
Tech Republic
| 06. 05. 2015
Untitled Document
Dan Lane has always had a keen interest in the next big thing. He owned an early set of Google Glass, got his first RFID implant 10 years ago. Working in technology, he'd always been curious to try out the latest piece of kit or new service. So when 23andMe, a company that offers customers insight into their own DNA, opened up in the UK, he decided he'd give that a try too.
23andMe works like this: you get sent a small tube in the post, you spit into it, and send it away to be analysed. That little sample of saliva may not seem like much, but it holds a few of your cheek cells, each of which contains your entire genome—all the DNA that makes you, you. A few weeks later after the tube arrives, 23andMe sends you back a personalised interpretation of your DNA.
Services like 23andMe can unpick your genome to discover information on a range of traits: how you react to certain drugs; your risk of developing particular diseases; what characteristics you might...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
